← Leaderboards
Amy E Foxx-Orenstein
Mayo Clinic
$354,105
Attributed
$354,105
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $138.9K · FY2005–06$200K$150K$100K$50K$0
'05
'06
Funding mix
By agency
NIH$354,105 · 3
By mechanism
R03$281,133 · 1
M01$72,972 · 2
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic
Same institution · by research overlap
- Yuri Ann Saito Loftus$1,180,621
- Ananda Basu$10,492,691
- Jean Fox$927
- Nicholas J Talley$2,189,145
- Vanda A Lennon$2,601,578
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationGastrointestinal Motility /PressureDrug Screening /EvaluationClinical ResearchHuman SubjectGastrointestinal Disorder ChemotherapyGastrointestinal FunctionGastrointestinal Sign /SymptomHormone TherapyInhibitor /AntagonistIntestine ObstructionNauseaNeurotransmitter AgonistNutrient Intake ActivityNutrition Related TagOctreotideOpioid ReceptorPatient Oriented ResearchPeptide Hormone AnalogSerotonin ReceptorSingle Photon Emission Computed TomographySomatostatinAutoradiographyStomach Emptying
Grant awards (4)
Synergism of prokinetics on human intestinal transit$138,895
R03 · FY2006 · DK · contact PI
STUDY OF THE EFFECTS OF TEGASEROD AND NALTREXONE ON COLONIC TRANSIT$40,991
M01 · FY2005 · RR
Synergism of prokinetics on human intestinal transit$142,238
R03 · FY2004 · DK
Dosage--Somatostatin Analog &Postprandial GI Functions$31,981
M01 · FY2004 · RR